Shuttle Pharmaceuticals Holdings (SHPH) Shares Outstanding (Diluted Average) (2022 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Shares Outstanding (Diluted Average) of $5.0 million in Q1 2026, up 207.19% quarter-over-quarter from $1.6 million in Q4 2025, and up 1151.77% on a YoY basis from $401957.0 in Q1 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Shares Outstanding (Diluted Average) (2022 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Shares Outstanding (Diluted Average) history runs 5 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Diluted Average) rose 1151.77% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $5.0 million (up 1151.77% YoY), while the FY2025 annual figure was $1.6 million, up 1318.2% from the prior year.
- Shares Outstanding (Diluted Average) was $5.0 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from $1.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $9.3 million in Q2 2022 to a low of $84197.0 in Q2 2024.
- Historically, Shares Outstanding (Diluted Average) has averaged $2.0 million across 5 years, with a median of $1.6 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) sank 95.56% in 2024, then surged 1341.7% in 2025.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $1.3 million in 2022, then soared by 39.51% to $1.9 million in 2023, then tumbled by 93.81% to $115493.0 in 2024, then surged by 1318.2% to $1.6 million in 2025, then surged by 207.19% to $5.0 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $5.0 million (Q1 2026), $1.6 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 2.17 Mn | 1.11 Mn | - | 5.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.03 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | 401,957.00 |
| Dec 31, 2024 | 115,493.00 |
| Sep 30, 2024 | 87,439.00 |
| Jun 30, 2024 | 84,197.00 |
| Mar 31, 2024 | 2.08 Mn |
| Dec 31, 2023 | 1.87 Mn |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 1.74 Mn |
| Mar 31, 2023 | 1.70 Mn |
| Dec 31, 2022 | 1.34 Mn |
| Jun 30, 2022 | 9.29 Mn |